EHTI to prove medtech can produce the added-value healthcare needs
This article was originally published in Clinica
Executive Summary
The European Health Technology Institute for Socio-Economic Research (EHTI) is producing evidence to prove how medtech products contribute to an efficient use of healthcare resources. Data is being uncovered which shows how medtech adds value in terms of health, quality of life, productivity and ultimately economic growth. And this provides a strong rationale why it should not be the target for further cost-cutting.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.